Hisashi Kato
Overview
Explore the profile of Hisashi Kato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wibowo T, Kogue Y, Ikeda S, Yaga M, Tachikawa M, Suga M, et al.
Mol Ther Methods Clin Dev
. 2024 Dec;
32(4):101374.
PMID: 39659759
Cord blood (CB)-derived chimeric antigen receptor (CAR)-natural killer (NK) cells targeting CD19 have been shown to be effective against B cell malignancies. While human CD56 NK cells can be expanded...
2.
Yamano A, Ozawa T, Endo T, Koike M, Kato H, Takahashi T, et al.
Intern Med
. 2024 Oct;
PMID: 39428525
A 79-year-old man with smoldering multiple myeloma (MM) developed sudden severe thrombocytopenia and active bleeding. Since anti-GPIIb/IIIa autoantibodies were detected on the platelet surface, thrombocytopenia due to an autoimmune etiology...
3.
Osawa S, Kato H, Kemmoku D, Yamaguchi S, Jiang L, Tsuchiya Y, et al.
Biochem Biophys Res Commun
. 2024 Jul;
734:150447.
PMID: 39083976
Adipose-derived stem cell (ASC)-released exosomes (ASCexos) have multiple biological activities. We examined the effect of ASCexos derived from the inguinal adipose tissue of exercise-trained rats (EX-ASCexos) on adipogenic conversion of...
4.
Rai S, Kim W, Ando K, Choi I, Izutsu K, Tsukamoto N, et al.
Haematologica
. 2024 Jun;
109(10):3357-3362.
PMID: 38841789
No abstract available.
5.
Izutsu K, Kato H, Sekiguchi N, Fujisaki T, Kawakita T, Obara N, et al.
Int J Hematol
. 2024 Apr;
120(1):80-90.
PMID: 38597986
Ibrutinib is a first-in-class Bruton kinase inhibitor against B-cell neoplasms including Waldenström macroglobulinemia (WM). This study evaluated the efficacy and safety of ibrutinib-rituximab in Japanese patients with WM. Patients received...
6.
Kato H, Iwashita K, Iwasa M, Kato S, Yamakage H, Suganami T, et al.
Cells
. 2024 Feb;
13(3.
PMID: 38334676
Type 2 diabetes mellitus (T2DM) is an epidemiological risk factor for dementia and has been implicated in multifactorial pathologies, including neuroinflammation. In the present study, we aimed to elucidate the...
7.
Seta S, Ota Y, Kato H, Nakanishi Y
Cureus
. 2024 Jan;
15(12):e51191.
PMID: 38283481
Spindle cell squamous cell carcinoma (SCSCC) represents a distinctive subtype of squamous cell carcinoma, characterized by a marked malignancy and sarcomatoid transformations predominantly comprising spindle-shaped cells. In this context, we...
8.
Kato H, Ogura G, Uchibori M, Nakanishi Y, Seta S, Kaneko A
Tokai J Exp Clin Med
. 2023 Nov;
48(4):139-143.
PMID: 37981851
The differential diagnosis of a tongue mass containing calcified bodies includes a phlebolith associated with vascular lesions, such as hemangioma and vascular malformation, and diseases such as neoplasm, osseous choristoma...
9.
Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J, et al.
Int J Hematol
. 2023 Nov;
119(1):1-13.
PMID: 37957517
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia due to accelerated platelet destruction and impaired platelet production. Diagnosis of ITP is still challenging because ITP has...
10.
Kato H
Rinsho Ketsueki
. 2023 Oct;
64(9):1106-1115.
PMID: 37899189
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by increased platelet destruction and impaired platelet production from bone marrow megakaryocytes. The details of different platelet destruction mechanisms resulting from differences...